Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Biocon has completed the acquisition of the remaining equity shares of its unlisted subsidiary Biocon Biologics from Mylan Inc for $200 million, taking its total stake in Biocon Biologics to about 98% ...

Biocon Limited ( (IN:BIOCON)) has issued an update. Biocon Limited has significantly increased its stake in its unlisted material subsidiary, Biocon Biologics Limited (BBL), through a combination of a ...

Biocon Ltd is quoting at Rs 373.85, up 0.42% on the day as on 12:44 IST on the NSE. The stock is down 4.2% in last one year as compared to a 8.62% gain in NIFTY and a 1.45% gain in the Nifty Pharma.

BRIDGEWATER, N.J. and BENGALURU, India, April 10, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the U.S. Food and ...

On Wednesday, Biocon stock slipped 0.55 per cent to settle at Rs 364.55 apiece on the BSE.

With eyes on expanding in North America and around the globe, Biocon has been busy in recent months. Biocon Generics, a unit of India’s Biocon Limited, just acquired (PDF) Eywa Pharma’s New Jersey ...

PITTSBURGH and BENGALURU, India, July 28, 2021 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS) and Biocon Biologics Ltd. (a subsidiary of Biocon Ltd.) today announced that the U.S. Food and Drug ...

BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars ...